Punam Sandhu

1.9k citations

25 papers · 1.1k indexed · h-index 16

Co-authors: F. Peter Guengerich T. Baba Robert H. Tukey Zhimou Guo M V Martin Paul G. Pearson Xin Xu Julie A. Stone
Topics: Pharmacogenetics and Drug Metabolism (11 papers)Antifungal resistance and susceptibility (4 papers)Nematode management and characterization studies (2 papers)
Cited by: Pharmacology Infectious Diseases Oncology
Journals: Cancer Research The FASEB Journal Antimicrobial Agents and Chemotherapy
Partner nations: United States Japan United Kingdom

In The Last Decade

Punam Sandhu

24 papers receiving 1.1k citations

Peers

Countries citing papers authored by Punam Sandhu

Since Specialization

Citations

This map shows the geographic impact of Punam Sandhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Punam Sandhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Punam Sandhu more than expected).

Fields of papers citing papers by Punam Sandhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Punam Sandhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Punam Sandhu. The network helps show where Punam Sandhu may publish in the future.

Co-authorship network of co-authors of Punam Sandhu

This figure shows the co-authorship network connecting the top 25 collaborators of Punam Sandhu. A scholar is included among the top collaborators of Punam Sandhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Punam Sandhu. Punam Sandhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhanced analysis of the genomic diversity of Mycobacterium bovis in Great Britain to aid control of bovine tuberculosis 2025 ·Frontiers in Microbiology ·Punam Sandhu,Javier Nuñéz-García,Stefan Berg,Jane C. Wheeler,James Dale,Paul Upton,J. C. Gibbens,R. Glyn Hewinson,Sara H. Downs,Richard J. Ellis,Eleftheria Palkopoulou	0
2	Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects 2018 ·Clinical Pharmacology & Therapeutics ·Yuki Matsumoto,Tamara D. Cabalu,Punam Sandhu,Georgy Hartmann,Takashi Iwasa,(unknown),Christopher R. Gibson,Naoto Uemura	14
3	Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: Model prediction and clinical confirmation 2014 ·The Journal of Clinical Pharmacology ·Mark Stroh,(unknown),Punam Sandhu,Jacqueline B. McCrea,Amita Patnaik,Anthony W. Tolcher,John Palcza,Keith Orford,Sheila Breidinger,Narayana I. Narasimhan,Deborah Panebianco,Richard M. Lush,Kyriakos P. Papadopoulos,John A. Wagner,Michele Trucksis,Nancy Agrawal	4
4	Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor 2013 ·Cancer Chemotherapy and Pharmacology ·Marian Iwamoto,Evan Friedman,Punam Sandhu,Nancy Agrawal,Eric H. Rubin,John A. Wagner	58
5	A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Helmut Glantschnig,Kevin R. Scott,Richard Hampton,Nan Wei,Paul J. McCracken,Pascale V. Nantermet,Jing Zhao,Salvatore Vitelli,Lingyi Huang,Peter Haytko,Ping Lü,John Fisher,Punam Sandhu,Jacquelynn J. Cook,(unknown),William R. Strohl,Osvaldo Flores,Donald B. Kimmel,Fubao Wang,Zhiqiang An	71
6	Disposition of Vorinostat, A Novel Histone Deacetylase Inhibitor and Anticancer Agent, in Preclinical Species 2007 ·Drug Metabolism Letters ·Punam Sandhu,Paul A. Andrews,(unknown),(unknown),(unknown),Thomas A. Miller,Thomas A. Baillie	31
7	HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN 2005 ·Drug Metabolism and Disposition ·Punam Sandhu,Wooin Lee,Xin Xu,Brenda F. Leake,Masayo Yamazaki,Julie A. Stone,Jiunn H. Lin,Paul G. Pearson,Richard B. Kim	83
8	EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE 2004 ·Drug Metabolism and Disposition ·Punam Sandhu,John S. Vogel,Mark J. Rose,Esther A. Ubick,(unknown),Michael A. Wallace,(unknown),(unknown),Paul T. Henderson,Paul G. Pearson,Thomas A. Baillie	45
9	Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma 2004 ·Antimicrobial Agents and Chemotherapy ·Julie A. Stone,Xin Xu,Gregory A. Winchell,Paul Deutsch,Paul G. Pearson,Elizabeth Migoya,Goutam C. Mistry,Liwen Xi,(unknown),Punam Sandhu,Romi Singh,F A deLuna,Stacy C. Dilzer,Kenneth C. Lasseter	111
10	Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Douglas W.P. Hay,Giuseppe Giardina,Don E. Griswold,David C. Underwood,Charles J. Kotzer,(unknown),W. M. Potts,Punam Sandhu,(unknown),James J. Foley,Dulcie B. Schmidt,Lenox D. Martin,David Kilian,Jeffrey J. Legos,Frank C. Barone,Mark A. Luttmann,Mario Grugni,Luca F. Raveglia,Henry M. Sarau	75
11	In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics 2001 ·Pharmacogenetics ·Cuyue Tang,Magang Shou,Thomas H. Rushmore,Mei Qin,Punam Sandhu,Eric Woolf,Mark J. Rose,(unknown),Howard Greenberg,Inge De Lepeleire,Anne Van Hecken,P.J. De Schepper,David L. Ebel,Jules I. Schwartz,A. David Rodrigues	96
12	Expression and Purification of Human Cytochrome-P450 Enzymes From Escherichia-Coli 1994 ·The FASEB Journal ·Zhan‐Yun Guo,Punam Sandhu,Elizabeth M. J. Gillam,(unknown),Guengerich Fp	1
13	Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays 1994 ·Carcinogenesis ·Tsutomu Shimada,Elizabeth M. J. Gillam,Punam Sandhu,Zuyu Guo,Robert H. Tukey,F. Peter Guengerich	56
14	Expression of Modified Human Cytochrome P450 1A2 in Escherichia coli: Stabilization, Purification, Spectral Characterization, and Catalytic Activities of the Enzyme 1994 ·Archives of Biochemistry and Biophysics ·Punam Sandhu,Zhimou Guo,T. Baba,M V Martin,Robert H. Tukey,F. Peter Guengerich	168
15	Expression of Human Cytochrome-P450 Enzymes in Escherichia-Coli, Purification, and Reconstitution of Catalytic Activity 1993 ·The FASEB Journal ·Punam Sandhu,Elizabeth M. J. Gillam,T. Baba,(unknown),Guengerich Fp	1
16	Expression of human cytochrome P450 enzymes in yeast and bacteria and relevance to studies on catalytic specificity 1993 ·Toxicology ·F. Peter Guengerich,Elizabeth M. J. Gillam,Shigeru Ohmori,Punam Sandhu,(unknown),Marie‐Agnès Sari,M. Iwasaki	17
17	Expression of Modified Cytochrome P450 2C10 (2C9) in Escherichia coli, Purification, and Reconstitution of Catalytic Activity 1993 ·Archives of Biochemistry and Biophysics ·Punam Sandhu,T. Baba,F. Peter Guengerich	100
18	Expression of Human Cytochrome-P-450-3A4 and Cytochrome-P450-2E1 in the Bacterium Escherichia-Coli 1992 ·The FASEB Journal ·Elizabeth M. J. Gillam,(unknown),Punam Sandhu,Guengerich Fp	4
19	Lack of release from hepatocytes in vitro or excretion in vivo of mutagenic chrysoidine metabolites 1991 ·Toxicology Letters ·Punam Sandhu,James Kevin Chipman	1
20	Bacterial mutagenesis and hepatocyte unscheduled DNA synthesis induced by chrysoidine azo-dye components 1990 ·Mutation Research/Genetic Toxicology ·Punam Sandhu,James Kevin Chipman	19

About Punam Sandhu

Punam Sandhu is a scholar working on Pharmacology, Small Animals and Infectious Diseases, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Antifungal resistance and susceptibility (4 papers) and Nematode management and characterization studies (2 papers). The work is most often cited by research in Pharmacology (411 citations), Infectious Diseases (202 citations) and Oncology (292 citations). Punam Sandhu has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include F. Peter Guengerich, T. Baba, Robert H. Tukey, Zhimou Guo, M V Martin, Paul G. Pearson, Xin Xu, Julie A. Stone, Elizabeth M. J. Gillam and Nancy Agrawal. Their work appears in journals such as Cancer Research, The FASEB Journal and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact